All Studies

The studies listed below explore the significant impact of type 2 diabetes (T2D) and cardiovascular disease (CVD) on healthcare costs and patient outcomes. Each poster is shown in detail and can be downloaded in full for further review.

The information in these studies may play a valuable role in finding solutions to optimize management of patients with T2D and reduce the risk of further comorbidities.

Newly Added

Economic Burden of Type 2 Diabetes Mellitus in Patients With Cardiovascular Disease in Commercially Insured Patients in the United States

Study Conducted by:
Wang W, Farrelly EM, Shetty S, et al.
Newly Added

Incremental Burden of Type 2 Diabetes Mellitus in Patients Hospitalized for Heart Failure

Study Conducted by:
Raju A, Coutinho AD, Wang W, et al.

Incremental Burden of Type 2 Diabetes Mellitus in Patients Experiencing Cardiovascular Hospitalizations

Study Conducted by:
Coutinho AD, Raju A, Wang W, et al.

Disproportionately High Direct Economic Burden of Type 2 Diabetes Mellitus Patients With Comorbid Cardiovascular Disease

Study Conducted by:
Sander SD, Lunacsek O, Stafkey-Mailey D, et al.

The Economic Burden of Patients With Type 2 Diabetes Mellitus Hospitalized for Heart Failure

Study Conducted by:
Stafkey-Mailey D, Fuldeore RM, Shetty S, et al.

The Direct Cost of Cardiovascular Disease-related Death in Patients with Type 2 Diabetes Mellitus in a Commercially Insured Population in the United States

Study Conducted by:
Shetty S, Stafkey-Mailey D, Yue B, et al.